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Abstract
Aims: Patients with spinal cord injury (SCI) are at risk of developing renal
calculi. This study describes the management of renal calculi among patients
with SCI with attention to factors influencing surgical management vs
observation.
Methods: This retrospective, cohort study identified patients with SCI and
renal calculi between 2009 to 2016 from an institutional neurogenic bladder
database and detailed the management of their stones. A stone episode was
defined as radiographic evidence of new calculi.
Results: Of 205 patients with SCI, 34 had renal stones, for a prevalence of 17%.
The mean age was 50 years (range 22,77) and most had cervical SCI (n = 22,
65%). There were 41 stone episodes with 98 individual stones identified with a
mean stone size of 4.9 mm (range 1‐19).
Of the 41 episodes, 10 (24%) underwent surgery after initial diagnosis. Pain was
the most common primary indication for surgery (n = 9, 60%). The median time
from diagnosis to intervention for all patients was 4 months (interquartile range
1,23). Of the 41 episodes, 31 (76%) were initially observed and among these, 5
ultimately required surgery (16%) while 26 (84%) did not. Of these 26, 12 (46%)
stones passed spontaneously and 14 (53%) remained unchanged. The need for
surgery correlated with more stone episodes (P= .049).
Conclusion: In this cohort of patients with SCI and small, nonobstructing
renal stones, 76% (n = 31) were offered observation. Of these observed patients,
84% (n = 26) did not require further intervention at a median of 4 years of
follow‐up.
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1 | INTRODUCTION
In the mid‐20th century, it was said that stone formation
was a great menace to the urinary tract in patients with
neurogenic bladder.1 In fact, between 1944 and 1969,
urogenital disease consisting of infections and renal
failure was the most common cause of death among
patients with spinal cord injury (SCI), accounting for
nearly 1/3 of deaths.2 Fortunately, the contemporary
management of neurogenic bladder has led to
improvements in the urogenital care of patients with SCI.
Now, the urogenital disease accounts for less than 10% of
death, representing the 4th cause of mortality since
1990.3,4 Recent estimates report that patients who survive
the first 3 years after SCI, will have between 48% and 84%
of the average normal life expectancy, depending on the
level of their SCI.4
The combination of urinary stasis, prolonged immo-
bility leading to resorptive hypercalciuria, and urinary
tract bacterial colonization with protease splitting organ-
isms places patients with SCI at increased risk of urinary
calculi formation.5,6 Their risk of stone formation is about
6 times greater than the general population.7
The Consortium for Spinal Cord Medicine Guidelines
for Bladder Management for Adults and the European
Association of Urology (EAU) Guidelines on Neurogenic
Bladder recommend urologic evaluation annually with
upper tract imaging every 6 to 12 months.8,9 This
surveillance imaging can lead to a finding of asympto-
matic calculi. However, there are currently no published
guidelines regarding the management of incidentally
found renal calculi in patients with SCI.
A study from our institution of 46 consecutive
patients with SCI undergoing ureteroscopy found that
21% of patients suffered a perioperative complication.5
Furthermore, achieving stone‐free status in this
population with minimally invasive surgery was
challenging, and in this study was reported in only
17% of patients.5
This current study aims to describe the manage-
ment of renal stones among patients with SCI at a
tertiary care center. Specifically, risk factors influen-
cing surgical vs conservative management of calculi
will be described.
2 | METHODS
Institutional review board approval was obtained for this
study (HUM 00031859). A prospectively maintained
institutional neurogenic bladder database was queried
to identify patients with SCI and history of renal or
ureteral calculi from 9/2009 until 12/2016. Demographic
data and clinical data pertinent to SCI, neurogenic
bladder, and urolithiasis diagnosis were retrieved from
the database.
Only patients with neurogenic bladder secondary to
SCI (traumatic or medical) were included. Spinal cord
injuries due to spinal tumors and transverse myelitis
were included in the population. Other causes of
neurogenic bladder, such as multiple sclerosis, myelo-
meningocele, cerebral palsy, sacral agenesis, pelvic nerve
injury, brain injury or systemic neurologic disease were
excluded. Furthermore, only renal calculi were included;
ureteral calculi and bladder calculi were excluded. A
stone episode was defined as radiographic evidence of a
new calculi(us) discovered by ultrasound (US) or
computed tomography (CT) obtained either for routine
screening, incidentally on imaging for other causes or for
patient symptoms. In this population, routine upper tract
surveillance with renal ultrasound is performed annually.
Indications for surgical intervention in this cohort follow
the 2018 European Association of Urology and the 2016
American Urological Association (AUA) guidelines.10,11
These include stone growth, stones in high‐risk patients
for ongoing formation, obstruction, infection, stones
>15mm, and patient preferences. Patients who do not
meet these criteria, qualify as meeting the basic safety
parameters for observation.
Descriptive statistics were utilized to evaluate the
population. For normally distributed data, mean and
standard deviations are reported, otherwise, medians
with interquartile ranges (Q1, Q3) are shown. Sub-
groups based on demographic or clinical variables were
evaluated and compared utilizing inferential statistics.
For normally distributed data, t test and analysis of
variance were utilized to compare continuous variables
and the chi‐squared test was utilized to compare
categorical variables. Fischer’s exact test was utilized if
there were less than 5 values within a group. For data
that were not normally distributed, nonparametric
tests were utilized. The level of significance was set at
P< .05. IBM SPSS® Statistics version 25 was utilized for
statistical analysis
3 | RESULTS
Of 315 patients within the neurogenic bladder database,
205 had SCI (190 traumatic or medical SCI, 9 transverse
myelitis, and 6 spinal tumors). Of these, 144 patients had
no stones on imaging, 25 patients had no imaging, and
36 patients had confirmed stones, 2 patients with ureteral
stones were excluded. Of the 34 patients with renal
stones, the mean age was 50 years (range 22‐77) (Table 1).
Patients sustained their SCI at a median age of 26 years
old (interquartile range [IQR] 16,43) (Table 1). The
median length of follow‐up following the patient’s first
stone episode was 4 years (IQR 2,6) (Table 2). The
majority of patients were male and Caucasian with
cervical SCI and ASIA A classification (Table 1). Over
half of the patients (n = 19, 56%) managed their bladder
with intermittent catheterization, whereas the remaining
half were divided between urinary diversion (n = 7, 21%)
and suprapubic tube (n = 6, 19 = 18%) (Table 1).
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A total of 98 stones were identified in these 34
patients with 41 stone episodes and a median of
2.5 stones per episode (IQR 1,4) (Table 2). Most patients
had only one stone episode (n = 29), several had
multiple, including one patient with five episodes. The
presence of stones was most commonly diagnosed by CT
(n = 19, 46%) and renal ultrasound (n = 19, 46%).
Imaging was obtained for neurogenic bladder surveil-
lance in 49% (n = 20), genitourinary symptoms (renal
colic) in 39% (n = 16), and non‐urologic symptoms in
12% (n = 5). As expected, imaging for neurogenic
bladder follow‐up was more commonly US than CT
(n = 14 vs 4, P= .12) (Table 3).
Out of each of the 98 stones identified, the mean
maximum stone diameter was 4.9 mm (range 1‐19mm).
Stone laterality was equally distributed between kidneys
(49% right, 51% left). However, there was a dispropor-
tionate amount of stone burden located at the lower pole
(n = 60, 61%). Four stones (3 episodes) were located at
the ureteropelvic junction (Figure 1).
In the 41 episodes, 4 (10%) patients underwent
immediate surgery (within 4 weeks) and 6 (15%)
underwent early surgery (within 12 months). The most
common indication for surgery in these 10 episodes was
flank or abdominal pain (n = 5) and infection occurred
only in 1 patient. The remaining 31 (75%) episodes were
initially managed with observation, and of these, 5 (16%)
ultimately required intervention at a median of 44
months (IQR 19, 67) after discovery. Reasons for surgery
in these five included flank or abdominal pain (n = 4)
and infection requiring hospitalization (n = 1). For the
26 (84%) episodes that continued on observation, 12
(39%) resolved with spontaneous stone passage, while
stones in the remaining 14 (45%) episodes were un-
changed (Figure 2).
Of the 34 patients, who had a total of 41 stone
episodes, 14 (41%) patients underwent surgical interven-
tion for renal calculi (one patient had two surgeries for
two separate stone episodes). Of the surgical interven-
tions performed, ureteroscopy was the most common
procedure (n = 10, 63% of all procedure) followed by
percutaneous nephrolithotomy (n = 3, 7%) (Figure 2).
There was no relationship between the mean number
of stones and demographics or bladder management
modality. Nor was there an association between a total
number of stones and age at SCI (P= .88) or age at
first intervention for nephrolithiasis (P= .33) (Table S1).
Subgroup analysis to evaluate which patients had risk
factors for intervention revealed that patients undergoing
surgery had more stone episodes (P= .049) than the
observed group. However, we did not find that the level
of SCI or ASIA classification was associated with whether
patients developed a symptomatic stone (P= .209 and
P= .780, respectively). Furthermore, spontaneous stone
passage was not correlated to stone diameter (P= .26),
laterality (P= .09), or location (P= .65).
TABLE 1 Patient characteristics
Number
%(n = 34)
Current age (mean, range) 50 (22‐77)
Age at spinal cord injury (SCI)
(median, IQR)
26 (16,43)
Gender: Male 26 77












Pulmonary disease 10 29
Cardiac disease 13 38
Diabetes mellitus 2 6
Chronic kidney disease 2 6
Venous thromboembolism 9 26
Bladder management
Voiding 2 6
Intermittent catheterization 19 56
Suprapubic tube 6 18
Urinary diversion 7 21
Abbreviation: IQR, interquartile range.
TABLE 3 Indications for imaging for each episode (n = 41)
N %
Neurogenic bladder screening 20 49
Genitourinary symptoms (flank pain, UTI) 16 39
Non‐GU symptoms 5 12





Age at first stone, y 47 34 58
Time between SCI and stone, y 7.5 3 29
Total no. stones per patient 2.5 1 4
Total follow‐up time, y 4 2 6
Abbreviation: IQR, interquartile range; SCI, spinal cord injury.
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4 | DISCUSSION
In this cohort, 31 of the 41 renal stone episodes (76%) in
patients with SCI were offered an initial observation. These
were small (mean 4.9mm, range 1‐19mm), nonobstructing
renal stones on imaging. Of these 31 episodes initially
observed, only 5 (16%) went on to require surgical
intervention, whereas the remaining 26 (84%) episodes
did not require intervention at a median follow‐up of
4 years. While the outcomes of surgical interventions
for nephrolithiasis in patients with SCI have been
described,5,12-15 to our knowledge no prior study has
described the clinical outcomes of observed calculi among
patients with SCI. In 2002, Chen described 77 patients with
SCI and renal stones, and within that cohort 60 patients
underwent conservative therapy with an 82% stone‐free
rate.16 However, the rate of failure of conservative therapy
(need for surgery) remained unknown. Understanding the
natural history of nephrolithiasis in patients with SCI is
paramount to informed decision making. This is because
patients with SCI are at increased odds of developing major
and minor complications after surgery for nephrolithiasis.
Therefore, it is important to discuss observation as an
option.12,17 For example, the rate of complications for
ureteroscopy and PCNL in patients with neurogenic
bladder ranges from 12% to 21%.5,6 Prior studies have
proposed that observation of recalcitrant stones in compli-
ant patients could be a reasonable approach to decrease
morbidity associated with surgical intervention.5
Our data suggest that observation of renal stones in
patients with SCI is a reasonable option in motivated patients
who are well informed of their stone status and have no
symptoms, infection, renal dysfunction and have small
stones (mean 4.9mm). Our data also suggests that only a
minority of stones eventually require intervention since
many pass spontaneously without symptoms or remain
indolent.
Both AUA and EAU guidelines advocate for conservative
management in patients with asymptomatic, nonobstructing
renal stones.10,11 In renal stones, the indications for surgical
removal include stone growth, stones in high‐risk patients for
ongoing formation, obstruction, infection, stones >15mm,
and patient preferences.10,11 It is important to note that our
findings apply only to patients with small (mean 4.9mm),
nonobstructing renal stones, who do not meet indications for
surgical removal as defined by these guidelines. For example,
in our study, 10 (24%) stone episodes underwent immediate
or early surgery since they did not meet these parameters.
Our practice remains to obtain upper tract surveillance
imaging every 12 months with renal ultrasound, and if small,
incidental, nonobstructing, renal stones are identified,
observation is offered to patients who meet these established
criteria.
FIGURE 1 Stone diameter and
frequency
FIGURE 2 Flow chart of patient management
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In this cohort, the majority of stones were small (mean
4.9mm), lower pole stones (60%). In a retrospective study of
160 renal stones, Dropkin reported that overall the majority
of stones (72%) remained asymptomatic over 3 years of
follow‐up.18 The authors also found that lower pole stones
were less likely than upper pole stones to become
symptomatic.18 It is important to note that there were
three stones that did cause a painless, silent obstruction in
their cohort. The safety of observation compared to surgical
intervention for small renal stones was also studied in a trial
of 150 patients randomized to observation, ureteroscopy, or
shock wave lithotripsy.19 In this study, 44 of the 50 patients
that were randomized to observation either passed their
stone or the stone remained unchanged.19 The remaining 6
(12%) patients required surgical intervention for the
development of symptoms or stone growth.19 The rate of
failing observation (requiring surgery), 12%, was within the
range of the rate of complications in the surgical groups (6%
to 14%).19 Accordingly, the authors found that the success
rates (noneventful ratio) (P= .80) and complication rates
(P= .56) among the groups were similar.19
The prevalence of renal calculi among patients with
SCI in our neurogenic bladder database was 16.6% (34/
205). This rate fits within the range of previously
published literature, (1.3% to 28%).7,20,21 This literature
however, was published between 1984‐2007, since that
time, diagnostic imaging has improved significantly and
in our study, 46% of stones were diagnosed by CT, which
has been demonstrated to be a more sensitive imaging
tool than US or plain film.22 In 2000, a study of over 8000
patients with SCI found that 3% of patients suffered from
kidney stones with an average of 13 years follow‐up after
injury.21 The same study predicted that within 10 years of
SCI, 7% of patients would develop a kidney stone.21
Kidney stone formation appears to be highest within
3 months of SCI (31 cases per 1000 person‐years) and
then reduces to 8 cases per 1000 after 8 years following
SCI.21 In our study, the median time between SCI and
the first stone was 8 years (IQR 3,30), which aligns with
this prior literature.21
While the data utilized for this current study was kept
as a prospectively curated database, the study is limited
due to its retrospective nature and small cohort. Only
health information available within the neurogenic
bladder database and the institutional electronic medical
record was included. This could have led to under‐
reporting of surgical interventions if patients sought
treatment at outside institutions. In addition, patients
with stones identified on renal ultrasound who elected
for observation did not routinely receive a confirmatory
CT scan. Therefore, the incidence of stone can be
overestimated by false positive renal ultrasounds. As part
of this study, we did not collect information on adverse
events, surgical outcomes nor on stone composition, all
of which would be helpful to note when discussing
options for management of calculi in patients with SCI.
5 | CONCLUSIONS
In this cohort of patients with SCI and small (mean
4.9mm), nonobstructing renal stones, 76% (n = 31) were
offered an observation based on established criteria. Of
these observed patients, 84% (n = 26) did not require
further intervention at a median of 4 years of follow‐up.
Future prospective studies focused on the adverse effects
of observation as compared to surgical intervention are
necessary.
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